Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rateOctober 20, 2020COVID-19 UpdatesHematologic Malignancies
Cancer researchers cross over to COVID-19 clinical trialsOctober 20, 2020COVID-19 UpdatesHematologic Malignancies
Meta-analysis: Acalabrutinib showed better PFS and OS than other frontline CLL therapiesOctober 7, 2020Hematologic Malignancies
Two new protein biomarkers may serve as prognostic indicators for outcomes in CLLSeptember 23, 2020Hematologic Malignancies
Review of Efficacy and Safety Outcomes of Ibrutinib in a Veteran Population with Chronic Lymphocytic LeukemiaSeptember 2, 2020OncologyHematologic Malignancies
Small Bowel Obstruction in a Surgically Naïve AbdomenMarch 6, 2020Mixed TopicsHematologic MalignanciesOncology
Levofloxacin prophylaxis improves survival in newly diagnosed myelomaNovember 1, 2019Multiple MyelomaHematologic Malignancies
‘Forward-Oriented’ Vector Holds Potential for Sickle Cell CureOctober 18, 2019Hematologic Malignancies
Stem cells gene edited to be HIV resistant treat ALL, but not HIVSeptember 11, 2019HIVInfectious DiseasesHematologic Malignancies
Genomic Medicine and Genetic Counseling in the Department of Veterans Affairs and Department of Defense (FULL)August 8, 2019OncologyBreast CancerProstate CancerHematologic Malignancies
SC daratumumab deemed feasible for every multiple myeloma patientJuly 11, 2019Multiple MyelomaHematologic Malignancies
Another study supports safety of 2-cm margins for thick melanomasJuly 11, 2019MelanomaHematologic Malignancies
Recombinant vaccine cut herpes zoster rate in immunocompromised patientsJuly 9, 2019VaccinesInfectious DiseasesMultiple MyelomaHematologic Malignancies
